SEC Form 4 · accession 0001181431-15-006871
Sagent Pharmaceuticals, Inc. · SGNT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Logerfo
Officer — President
Period of report
May 11, 2015
Accepted (ET)
May 13, 2015 · 4:49 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001369786
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 11, 2015 | M | 2,759 | $4.31 | A | 56,482 | D | |
| Common StockF1 | holding | — | — | — | 1,000 | I | See Footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option to BuyF2 | $4.31 | May 11, 2015 | M | 2,759 | D | — | Jul 23, 2020 | Common Stock | 2,759 | 10,000 | D |
Explanation of responses
- F1Shares held by a member of Mr. Logerfo's immediate family sharing the same household. Mr. Logerfo disclaims beneficial ownership of such shares.
- F2Stock option granted on July 23, 2010 and vests 25% per year over four years.